The PULSED AF Post-Approval Study is a research project to see how well a device called the PulseSelect™ PFA System works. This device is used to treat a heart condition called atrial fibrillation (AF), which causes irregular heartbeats. The study is observational, meaning doctors will watch and record how the treatment goes without making changes to it. Participants are followed for 36 months, with check-ups at 3, 6, 12, 24, and 36 months. These include a special heart test called a 24-hour Holter monitor to record heartbeats over a day.
- Study Length: 36 months with multiple check-ups.
- Eligibility: Adults with certain types of AF, not helped by other drugs, and who agree to the study rules.
- Risks: No major changes to treatment; just monitoring.